Visipaque 270 mg/mL
Visipaque 270 mg/mL is a medicine authorised by Swissmedic under authorisation number 52228. The authorisation holder is GE Healthcare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 April 1994 and the authorisation is valid without a time limit. ATC code V08AB09 places the medicine in the group Contrast media.
| Authorisation number | 52228 |
|---|---|
| Name | Visipaque 270 mg/mL |
| Full name | Visipaque 270 mg/mL, Injektionslösung |
| Authorisation holder | GE Healthcare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | V08AB09 |
| First authorisation | 15 April 1994 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Visipaque 270 mg/mL, Injektionslösung | B | 15 April 1994 |
| 3 | Visipaque 320 mg/mL, Injektionslösung | B | 15 April 1994 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 93 | 1 x 20 | ml | V08AB09 | 14.01.0. | B |
| 107 | 10 x 20 | ml | V08AB09 | 14.01.0. | B |
| 409 | 1 x 100 | ml | V08AB09 | 14.01.0. | B |
| 417 | 10 x 100 | ml | V08AB09 | 14.01.0. | B |
| 425 | 1 x 200 | ml | V08AB09 | 14.01.0. | B |
| 433 | 10 x 200 | ml | V08AB09 | 14.01.0. | B |
| 441 | 1 x 500 | ml | V08AB09 | 14.01.0. | B |
| 468 | 6 x 500 | ml | V08AB09 | 14.01.0. | B |
| 530 | 1 x 50 | ml | V08AB09 | 14.01.0. | B |
| 538 | 10 x 50 | ml | V08AB09 | 14.01.0. | B |
| 182 | 1 x 20 | ml | V08AB09 | 14.01.0. | B |
| 190 | 10 x 20 | ml | V08AB09 | 14.01.0. | B |
| 476 | 1 x 100 | ml | V08AB09 | 14.01.0. | B |
| 484 | 10 x 100 | ml | V08AB09 | 14.01.0. | B |
| 492 | 1 x 200 | ml | V08AB09 | 14.01.0. | B |
| 506 | 10 x 200 | ml | V08AB09 | 14.01.0. | B |
| 514 | 1 x 500 | ml | V08AB09 | 14.01.0. | B |
| 522 | 6 x 500 | ml | V08AB09 | 14.01.0. | B |
| 546 | 1 x 50 | ml | V08AB09 | 14.01.0. | B |
| 554 | 10 x 50 | ml | V08AB09 | 14.01.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Visipaque 270 mg/mL authorised in Switzerland?
Yes. Visipaque 270 mg/mL is authorised by Swissmedic under authorisation number 52228, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Visipaque 270 mg/mL have?
Visipaque 270 mg/mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Visipaque 270 mg/mL?
The authorisation holder is GE Healthcare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.